2022 annual financial data
Regencell Bioscience 2022 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -7,617,770 USD and net income was -7,422,728 USD.
Operating cash flow was -5,267,055 USD.
Get free Regencell Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -7,617,770 USD
- Net income
- -7,422,728 USD
- Operating cash flow
- -5,267,055 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Regencell Bioscience financial years